Company: VERA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-314244
Chunk: 71

Company: Vera Therapeutics, Inc.
Filing Date: 2025-12-10
Form: 424B5
Chunk 71
---
 selling securityholders may offer under this prospectus, as well as any related free writing prospectuses, and the complete form of warrant and/or the warrant agreement and warrant certificate, as applicable, and any supplemental agreements, that contain the terms of the warrants. General We will describe in the applicable prospectus supplement the terms relating to a series of warrants being offered, including:

| • |     | the title of such securities; |

| • |     | the offering price or prices and aggregate number of warrants offered; |

| • |     | the currency or currencies for which the warrants may be purchased; |

| • |     | if applicable, the designation and terms of the securities with which the warrants are issued and the number of 
 warrants issued with each such security or each principal amount of such security;                              |

| • |     | if applicable, the date on and after which the warrants and the related securities will be separately 
 transferable;                                                                                         |

| • |     | if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; |

| • |     | in the case of warrants to purchase Class A common stock, the number of shares of Class A common stock                                            
 purchasable upon the exercise of one warrant and the price at which, and the currency in which, these shares may be purchased upon such exercise; |

| • |     | in the case of warrants to purchase preferred stock, the number of shares of preferred stock purchasable upon the            
 exercise of one warrant and the price at which, and the currency in which, these shares may be purchased upon such exercise; |

22

| • |     | in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon                                        
 exercise of one warrant and the price at which, and currency in which, this principal amount of debt securities may be purchased upon such exercise; |

| • |     | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and 
 the warrants;                                                                                                    |

| • |     | the terms of any rights to redeem or call the warrants; |

| • |     | the terms of any rights to force exercise of the warrants; |

| • |     | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise 
 of the warrants;                                                                                                  |

| • |     | the dates on which the right to exercise the warrants will commence and expire; |

| •